Literature DB >> 14635088

Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells.

Joann Zhang1, Jocelyn C Hsu B A, Matthew A Kinseth B A, Leonard F Bjeldanes, Gary L Firestone.   

Abstract

BACKGROUND: Indole-3-carbinol (I3C), a naturally occurring component of Brassica vegetables, such as cabbage, broccoli, and Brussels sprouts, is a promising anticancer agent for certain reproductive tumor cells. The objective of the current study was to characterize the cell cycle effects of I3C in human prostate carcinoma cells.
METHODS: The incorporation of [(3)H]thymidine and flow cytometry of propidium iodide-stained nuclei were used to monitor I3C-regulated changes in prostate carcinoma cell proliferation and cell cycle progression. Western blotting was used to document expression changes in cell cycle components and prostate-specific antigen (PSA) levels. The enzymatic activities of cyclin-dependent kinases (CDK) were tested by in vitro protein kinase assays using the retinoblastoma protein as a substrate.
RESULTS: I3C suppressed the growth of LNCaP prostate carcinoma cells in a dose-dependent manner by inducing a G1 block in cell cycle progression. I3C selectively inhibited the expression of CDK6 protein and transcripts and strongly stimulated the production of the p16 CDK inhibitor. In vitro protein kinase assays revealed the striking inhibition by I3C of immunoprecipitated CDK2 enzymatic activity and the relatively minor down-regulation of CDK4 enzymatic activity. In LNCaP prostate carcinoma cells, I3C treatment inhibited production of PSA, whereas combinations of I3C and the androgen antagonist flutamide more effectively inhibited DNA synthesis and PSA levels compared with either agent alone.
CONCLUSIONS: The results of the current study demonstrated that I3C has a potent antiproliferative effect in LNCaP and other human prostate carcinoma cells. These findings implicate this dietary indole as a potential chemotherapeutic agent for controlling the growth of human prostate carcinoma cells. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14635088     DOI: 10.1002/cncr.11844

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  22 in total

1.  A novel mechanism of indole-3-carbinol effects on breast carcinogenesis involves induction of Cdc25A degradation.

Authors:  Yongsheng Wu; Xiaoling Feng; Yucui Jin; Zhaojia Wu; William Hankey; Carolyn Paisie; Lei Li; Fengjuan Liu; Sanford H Barsky; Weiwei Zhang; Ramesh Ganju; Xianghong Zou
Journal:  Cancer Prev Res (Phila)       Date:  2010-06-29

2.  Indole-3-carbinol suppresses NF-kappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells.

Authors:  Yasunari Takada; Michael Andreeff; Bharat B Aggarwal
Journal:  Blood       Date:  2005-04-05       Impact factor: 22.113

3.  (3-Chloroacetyl)-indole, a novel allosteric AKT inhibitor, suppresses colon cancer growth in vitro and in vivo.

Authors:  Dong Joon Kim; Kanamata Reddy; Myoung Ok Kim; Yan Li; Janos Nadas; Yong-Yeon Cho; Jong-Eun Kim; Jung-Hyun Shim; Nu Ry Song; Andria Carper; Ronald A Lubet; Ann M Bode; Zigang Dong
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-01

4.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

5.  1-Benzyl-indole-3-carbinol is a novel indole-3-carbinol derivative with significantly enhanced potency of anti-proliferative and anti-estrogenic properties in human breast cancer cells.

Authors:  Hanh H Nguyen; Sergey N Lavrenov; Shyam N Sundar; David H H Nguyen; Min Tseng; Crystal N Marconett; Jenny Kung; Richard E Staub; Maria N Preobrazhenskaya; Leonard F Bjeldanes; Gary L Firestone
Journal:  Chem Biol Interact       Date:  2010-06-02       Impact factor: 5.192

6.  Development of β-amino-carbonyl compounds as androgen receptor antagonists.

Authors:  Zhi-yun Zhang; Yan-hui Zhu; Cai-hong Zhou; Qing Liu; Hui-li Lu; Yun-jun Ge; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

7.  Indole-3-carbinol inhibits MDA-MB-231 breast cancer cell motility and induces stress fibers and focal adhesion formation by activation of Rho kinase activity.

Authors:  Christine T Brew; Ida Aronchik; Karena Kosco; Jasmine McCammon; Leonard F Bjeldanes; Gary L Firestone
Journal:  Int J Cancer       Date:  2009-05-15       Impact factor: 7.396

Review 8.  Minireview: modulation of hormone receptor signaling by dietary anticancer indoles.

Authors:  Gary L Firestone; Shyam N Sundar
Journal:  Mol Endocrinol       Date:  2009-10-16

Review 9.  Antioxidant function of isoflavone and 3,3'-diindolylmethane: are they important for cancer prevention and therapy?

Authors:  Yiwei Li; Dejuan Kong; Aamir Ahmad; Bin Bao; Fazlul H Sarkar
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

10.  Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells.

Authors:  Hyun Ju Choi; Do Young Lim; Jung Han Yoon Park
Journal:  BMC Gastroenterol       Date:  2009-05-29       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.